Skip to main content
. 2021 Aug 3;269(3):1591–1599. doi: 10.1007/s00415-021-10728-x

Table 1.

Demographic and clinical characteristics of HC, PD-non pRBD, and PD-pRBD females and males

HC PD-non pRBD PD-pRBD Sex main effect test stat (P value)
Age, years
 F 60.6 (5.9) 60.9 (7.4) 63.5 (7.5) 6.215 (0.013)*
 M 64.1 (7.1) 63.2 (7.4) 64.7 (7.0)
Education, years
 F 16.2 (2.9) 15.4 (2.9) 15.2 (3.1) 3.141 (0.077)
 M 17.0 (2.5) 15.8 (3.0) 16.1 (2.9)
Age of onset, years
 F NA 60.0 (7.4) 62.6 (7.6) 2.348 (0.127)
 M NA 62.3 (7.2) 63.6 (6.9)
PD duration, months
 F NA 10.8 (8.5) 9.9 (6.8) 0.278 (0.599)
 M NA 10.3 (6.2) 11.6 (7.2)
MDS-UPDRS
 F NA 28.4 (10.0) 32.0 (11.9) 3.774 (0.053)
 M NA 30.1 (11.3) 37.4 (14.1)
MDS-UPDRS Part III
 F NA 19.0 (7.6) 17.9 (7.6) 7.371 (0.007)**
 M NA 20.4 (8.3) 23.3 (9.4)
H&Y stage, n, 1/2/3
 F NA 1.7 (2.1) 2.6 (2.5) 0.002 (0.967)
 M NA 35/37/1 21/33/0
GDS-15
 F 1.9 (3.2) 1.7 (2.1) 2.6 (2.5) 0.002 (0.967)
 M 1.2 (2.8) 2.3 (2.2) 2.7 (2.4)
ESS
 F 4.6 (2.9) 4.9 (3.4) 6.8 (3.6) 0.822 (0.365)
 M 5.3 (3.5) 5.7 (2.9) 6.4 (3.7)
RBDSQ
 F 1.5 (1.2) 2.7 (1.1) 6.0 (1.4) 7.405 (0.007)**
 M 1.9 (1.4) 2.6 (1.1) 7.2 (1.9)
UPSIT
 F 34.9 (3.4) 23.8 (8.6) 21.4 (8.7) 3.401 (0.066)
 M 33.6 (4.1) 21.0 (7.4) 18.7 (8.0)

Data are presented by groups as mean (SD), except for H&Y. Two-way analyses of variance (ANOVA) followed by Bonferroni post hoc tests were used for all demographic variables. Two-way analyses of covariance (ANCOVA) with age as covariable, followed by Bonferroni post hoc tests were used for all clinical variables. Except for MDS-UPDRS, that was analyzed by two-way analysis of variance (ANOVA); and H&Y, by Pearson’s Chi-squared

ESS Epworth Sleepiness Scale; F female; GDS-15 the 15-item Geriatric Depression Scale; HC healthy controls; H&Y Hoehn and Yahr scale; M male; MDS-UPDRS Movement Disorder Society Unified Parkinson’s Disease Rating Scale; PD-non pRBD PD without probable RBD; PD-pRBD PD with probable RBD; RBDSQ REM Sleep Behavior Disorder Screening Questionnaire; UPSIT University of Pennsylvania Smell Identification Test

*Sex differences in HC group (P < 0.05)

**Sex differences in PD-pRBD group (P < 0.05)